Home › NDC Lookup › Ingredients › Redness Reliever Lubricant Eye Drops › 87770-0001-01
👁️image loading
(from DailyMed)

VitaPhyte Redness Reliever Lubricant Eye Drops 5 mg/100g; 400 1 g/100g Solution, 15 g

by Guangzhou Liyan Cosmetics Technology Co., Ltd. · .15 g in 1 BOX (87770-001-01)
NDC 87770-0001-01
🏷️ FDA NDC (as labeled) 87770-001-01 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 87770-001-01
Product NDC 87770-001
11-digit billing NDC 87770000101
RxCUI 996209
UNII S9U025Y077, B697894SGQ
Application # M018
SPL Set ID 53d4e9b0-c9a0-797a-e063-6294a90ad0cf
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-03-05
Route OPHTHALMIC
Dosage form SOLUTION
Substance TETRAHYDROZOLINE; POLYETHYLENE GLYCOL 400
Why two NDCs? The FDA registers this code as 87770-001-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87770-0001-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Sympathomimetics, plain class.

Drug family (ATC) Sympathomimetics, plain, Sympathomimetics used as decongestants
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerGuangzhou Liyan Cosmetics Technology Co., Ltd.
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code87770
First marketedMar 2026
Product typeHuman Otc Drug
Portfolio8 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

VitaPhyte Redness Reliever Lubricant Eye Drops is an over-the-counter eye solution containing polyethylene glycol 400 and tetrahydrozoline. Polyethylene glycol functions as an artificial tear, commonly used to lubricate dry or irritated eyes. Tetrahydrozoline is a decongestant typically used to temporarily reduce redness caused by minor eye irritation. This product is marketed under FDA's over-the-counter monograph rules for eye drops and is applied directly to the eye.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Foster and Thrive Advanced Relief Eye Drops .05 g/100mL; 400 1 g/100mL 70677-1158-01 Strategic 1 bottle $0.134 — Availability likely —
Glitch Advanced Relief Eye Drops 400 1 g/100mL; .05 g/100mL 00276-0801-15 Misemer 1 bottle — — FDA listed —
Visine Red Eye Hydrating Comfort Eye Drops .5 mg/mL; 400 10 mg/mL 53209-6001-01 Morning 1 bottle — — FDA listed —
Family Wellness Advanced Redness Relief Eye Drops 400 1 g/100mL; .05 g/100mL 55319-0906-01 Family 1 bottle — — FDA listed —
Visine Red Eye Hydrating Comfort, CVP .5 mg/mL; 400 10 mg/mL 66715-6584-08 Lil' 1 bottle — — FDA listed —
Visine Red Eye Hydrating Comfort Eye Drops .5 mg/mL; 400 10 mg/mL 67751-0198-01 Navajo 1 bottle — — FDA listed —
Value Health by Prodose Eye Drops .5 mg/mL; 400 10 mg/mL 68210-5059-01 Prodose, 1 bottle — — FDA listed —
Visine Red Eye Hydrating Comfort Eye Drops .5 mg/mL; 400 10 mg/mL 69968-0356-01 Kenvue 700 bottles — — FDA listed —
Code Red Eye Drops Redness Relief 400 1 g/100mL; .05 g/100mL 83817-0963-01 4 1 bottle — — FDA listed —
VitaPhyte Redness Reliever Lubricant Eye Drops 5 mg/100g; 400 1 g/100gthis 87770-0001-01 Guangzhou 15 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2026
On the market since
Mar 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
87770-0001-01 You're viewing this .15 g in 1 BOX (87770-001-01) 2026-06-03 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 87770-001-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 87770-0001-01, written without dashes as 87770000101. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 87770-0001-01, the first segment (87770) is the labeler code FDA assigned to Guangzhou Liyan Cosmetics Technology Co., Ltd.; the middle segment (0001) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Guangzhou Liyan Cosmetics Technology Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Guangzhou Liyan Cosmetics Technology Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 51 words ▾

Uses • relieves redness caused by minor eye irritation • provides soothing moisture for dry, tired, or irritated eyes • helps protect eyes from dryness caused by screen time, wind, dust, or sunlight • temporarily relieves burning and discomfort associated with dry eyes • lubricates and refreshes eyes for long-lasting comfort

⏱️ Dosage and Administration 80 words ▾

Directions • adults and children 6 years of age and over: instill 1 to 2 drops in the affected eye(s) as needed, up to 4 times daily • for severe dryness or irritation: may be used throughout the day as directed by a doctor • remove contact lenses before use and wait at least 10 minutes before reinserting • children under 6 years of age: consult a doctor before use • children under 2 years of age: do not use

⚠️ Warnings 138 words ▾

Warnings For external use only. Ask a doctor before use if you have • glaucoma or other serious eye conditions • persistent eye redness or pain When using this product • do not touch the tip of the container to any surface • remove contact lenses before application • temporary blurred vision or mild stinging may occur • overuse may increase eye redness • discontinue use if solution changes color or becomes cloudy • replace cap tightly after each use Stop use and ask a doctor if • eye pain or irritation worsens • redness persists for more than 72 hours • vision changes occur • symptoms do not improve Keep out of reach of children.

If swallowed, seek medical assistance or contact a Poison Control Center immediately. If pregnant or breast-feeding, consult a healthcare professional before use.

🧪 Inactive Ingredients 31 words ▾

Purified Water Glycerin Sodium Hyaluronate Honey Extract(Jimerito Bee Honey) Boric Acid Sodium Borate Potassium Chloride Magnesium Chloride Sodium Chloride Glycine Hydrochloric Acid and/or Sodium Hydroxide may be used to adjust pH.

🎯 Purpose 12 words ▾

Polyethylene Glycol 400 1% → Lubricant Tetrahydrozoline HCl 0.05% → Redness reliever

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 87767-0001-01 · BRAND 87770-0002-01 · Guangzhou →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.